<html><head><title>Last Compo GREAT POINT PARTNERS LLC</title></head><link rel="stylesheet" type="text/css" href="alphaleague_style.css"/>
                  <body><h2>GREAT POINT PARTNERS LLC<br>#assets : 34<br>AUMs(M$) : 1,112</h2><table border="1" class="dataframe mystyle">
  <thead>
    <tr style="text-align: center;">
      <th></th>
      <th>name</th>
      <th>rpt_dt</th>
      <th>w</th>
      <th>name_prev</th>
      <th>rpt_dt_prev</th>
      <th>w_prev</th>
      <th>dw</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>462260100</th>
      <td>IOVANCE BIOTHERAPEUTICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">11.4</div></td>
      <td>IOVANCE BIOTHERAPEUTICS INC</td>
      <td>30June20</td>
      <td>8.1</td>
      <td><div p style="color:black;background:#dbfad2;">3.3</div></td>
    </tr>
    <tr>
      <th>78667J108</th>
      <td>SAGE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">10.8</div></td>
      <td>SAGE THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>6.9</td>
      <td><div p style="color:black;background:#dbfad2;">3.9</div></td>
    </tr>
    <tr>
      <th>004225108</th>
      <td>ACADIA PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>7.1</td>
      <td>ACADIA PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>6.9</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>040047607</th>
      <td>ARENA PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>6.7</td>
      <td>ARENA PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>6.5</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>98985W102</th>
      <td>ZYMEWORKS INC</td>
      <td>30September20</td>
      <td>6.5</td>
      <td>ZYMEWORKS INC</td>
      <td>30June20</td>
      <td>7.4</td>
      <td>-0.9</td>
    </tr>
    <tr>
      <th>91307C102</th>
      <td>UNITED THERAPEUTICS CORP DEL</td>
      <td>30September20</td>
      <td>5.8</td>
      <td>UNITED THERAPEUTICS CORP DEL</td>
      <td>30June20</td>
      <td>5.9</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>23282W605</th>
      <td>CYTOKINETICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">5.3</div></td>
      <td>CYTOKINETICS INC</td>
      <td>30June20</td>
      <td>2.8</td>
      <td><div p style="color:black;background:#dbfad2;">2.5</div></td>
    </tr>
    <tr>
      <th>210373106</th>
      <td>CONSTELLATION PHARMCETICLS I</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#f5d2ce;">5.2</div></td>
      <td>CONSTELLATION PHARMCETICLS I</td>
      <td>30June20</td>
      <td>8.3</td>
      <td><div p style="color:black;background:#f5d2ce;">-3.1</div></td>
    </tr>
    <tr>
      <th>36197T103</th>
      <td>GW PHARMACEUTICALS PLC</td>
      <td>30September20</td>
      <td>4.5</td>
      <td>GW PHARMACEUTICALS PLC</td>
      <td>30June20</td>
      <td>4.4</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>88322Q108</th>
      <td>TG THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>3.8</td>
      <td>TG THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>5.1</td>
      <td>-1.3</td>
    </tr>
    <tr>
      <th>556099109</th>
      <td>MACROGENICS INC</td>
      <td>30September20</td>
      <td>3.4</td>
      <td>MACROGENICS INC</td>
      <td>30June20</td>
      <td>3.3</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>05156V102</th>
      <td>AURINIA PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">3.2</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">3.2</div></td>
    </tr>
    <tr>
      <th>37890U108</th>
      <td>GLOBAL BLOOD THERAPEUTICS IN</td>
      <td>30September20</td>
      <td>3.2</td>
      <td>GLOBAL BLOOD THERAPEUTICS IN</td>
      <td>30June20</td>
      <td>2.7</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>G11196105</th>
      <td>BIOHAVEN PHARMACTL HLDG CO L</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#f5d2ce;">2.5</div></td>
      <td>BIOHAVEN PHARMACTL HLDG CO L</td>
      <td>30June20</td>
      <td>4.9</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.4</div></td>
    </tr>
    <tr>
      <th>92346J108</th>
      <td>VERICEL CORP</td>
      <td>30September20</td>
      <td>2.4</td>
      <td>VERICEL CORP</td>
      <td>30June20</td>
      <td>1.7</td>
      <td>0.7</td>
    </tr>
    <tr>
      <th>377322102</th>
      <td>GLAUKOS CORP</td>
      <td>30September20</td>
      <td>1.9</td>
      <td>GLAUKOS CORP</td>
      <td>30June20</td>
      <td>1.5</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>374163103</th>
      <td>GERON CORP</td>
      <td>30September20</td>
      <td>1.5</td>
      <td>GERON CORP</td>
      <td>30June20</td>
      <td>2.6</td>
      <td>-1.1</td>
    </tr>
    <tr>
      <th>800677106</th>
      <td>SANGAMO THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>SANGAMO THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.1</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>G72800108</th>
      <td>PROTHENA CORP PLC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>PROTHENA CORP PLC</td>
      <td>30June20</td>
      <td>1.7</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>16383L106</th>
      <td>CHEMOCENTRYX INC</td>
      <td>30September20</td>
      <td>1.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.2</td>
    </tr>
    <tr>
      <th>89374L104</th>
      <td>TRANSLATE BIO INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.1</td>
    </tr>
    <tr>
      <th>019770106</th>
      <td>ALLOGENE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.1</td>
    </tr>
    <tr>
      <th>74587V107</th>
      <td>PUMA BIOTECHNOLOGY INC</td>
      <td>30September20</td>
      <td>1.0</td>
      <td>PUMA BIOTECHNOLOGY INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>1.0</td>
    </tr>
    <tr>
      <th>46124U107</th>
      <td>INVENTIVA SA</td>
      <td>30September20</td>
      <td>1.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.0</td>
    </tr>
    <tr>
      <th>46071F103</th>
      <td>INTERSECT ENT INC</td>
      <td>30September20</td>
      <td>1.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.0</td>
    </tr>
    <tr>
      <th>13089P101</th>
      <td>CALITHERA BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>CALITHERA BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>0.9</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>92672L107</th>
      <td>VIEWRAY INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>VIEWRAY INC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>48283N106</th>
      <td>KADMON HLDGS INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>KADMON HLDGS INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>0.6</td>
    </tr>
    <tr>
      <th>516544103</th>
      <td>LANTHEUS HLDGS INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.6</td>
    </tr>
    <tr>
      <th>53635D202</th>
      <td>LIQUIDIA TECHNOLOGIES INC</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>LIQUIDIA TECHNOLOGIES INC</td>
      <td>30June20</td>
      <td>0.8</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>00289Y107</th>
      <td>ABEONA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>ABEONA THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.6</td>
      <td>-1.3</td>
    </tr>
    <tr>
      <th>69242L106</th>
      <td>OYSTER PT PHARMA INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>OYSTER PT PHARMA INC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>60040X103</th>
      <td>MILLENDO THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>MILLENDO THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>00972D105</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>AKEBIA THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>3.8</td>
      <td><div p style="color:black;background:#f5d2ce;">-3.8</div></td>
    </tr>
    <tr>
      <th>65343E108</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>NEXTCURE INC</td>
      <td>30June20</td>
      <td>1.7</td>
      <td>-1.7</td>
    </tr>
    <tr>
      <th>608550109</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>MOLECULAR TEMPLATES INC</td>
      <td>30June20</td>
      <td>1.4</td>
      <td>-1.4</td>
    </tr>
    <tr>
      <th>69366J200</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>PTC THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.3</td>
      <td>-1.3</td>
    </tr>
    <tr>
      <th>05465P101</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>AXONICS MODULATION TECHNOLOG</td>
      <td>30June20</td>
      <td>1.2</td>
      <td>-1.2</td>
    </tr>
    <tr>
      <th>23284F105</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>CYTOMX THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.9</td>
      <td>-0.9</td>
    </tr>
    <tr>
      <th>04335A105</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>ARVINAS INC</td>
      <td>30June20</td>
      <td>0.5</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>24823R105</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>DENALI THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.5</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>00434H108</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>ACCELERON PHARMA INC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>64049K104</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>NEOLEUKIN THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
  </tbody>
</table></body></html>.